Total Payments
$198,301
2024 Payments
$46,338
Companies
28
Transactions
217
Medicare Patients
1,895
Medicare Billing
$224,485
Payment Breakdown by Category
Consulting$176,671 (89.1%)
Other$9,944 (5.0%)
Food & Beverage$5,826 (2.9%)
Travel$4,740 (2.4%)
Research$1,000 (0.5%)
Education$120.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $176,671 | 73 | 89.1% |
| Honoraria | $9,944 | 8 | 5.0% |
| Food and Beverage | $5,826 | 123 | 2.9% |
| Travel and Lodging | $4,740 | 6 | 2.4% |
| Unspecified | $1,000 | 1 | 0.5% |
| Education | $120.00 | 6 | 0.1% |
Payments by Type
General
$197,301
216 transactions
Research
$1,000
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dompe US, Inc. | $94,627 | 41 | $0 (2024) |
| Shire North American Group Inc | $17,709 | 24 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $13,878 | 21 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $13,559 | 20 | $0 (2022) |
| SANOFI US SERVICES INC. | $12,650 | 2 | $0 (2021) |
| Allergan, Inc. | $9,435 | 9 | $0 (2020) |
| Amgen Inc. | $8,988 | 11 | $0 (2024) |
| Alcon Research LLC | $6,000 | 1 | $0 (2024) |
| TISSUETECH, INC. | $5,565 | 10 | $0 (2021) |
| Horizon Therapeutics plc | $4,242 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,338 | 46 | Dompe US, Inc. ($27,643) |
| 2023 | $56,426 | 31 | Dompe US, Inc. ($50,355) |
| 2022 | $7,054 | 15 | Kala Pharmaceuticals, Inc. ($6,037) |
| 2021 | $29,708 | 30 | SANOFI-AVENTIS U.S. LLC ($13,878) |
| 2020 | $8,701 | 10 | Kala Pharmaceuticals, Inc. ($4,500) |
| 2019 | $19,666 | 37 | Dompe US, Inc. ($12,413) |
| 2018 | $23,322 | 32 | Shire North American Group Inc ($13,376) |
| 2017 | $7,087 | 16 | Shire North American Group Inc ($4,067) |
All Payment Transactions
217 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $143.53 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Travel and Lodging | In-kind items and services | $56.11 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Dompe US, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 10/24/2024 | Dompe US, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 10/19/2024 | Dompe US, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 10/18/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $142.07 | General |
| 10/04/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $42.51 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Ophthalmology | ||||||
| 08/30/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Ophthalmology | ||||||
| 08/21/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/21/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/01/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $38.56 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/18/2024 | AXOGEN | Avance Nerve Graft (Device), AxoGuard Nerve Connector, AxoGuard Nerve Protector | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 07/18/2024 | AXOGEN | Avance Nerve Graft (Device), AxoGuard Nerve Connector, AxoGuard Nerve Protector | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| Category: Neurology | ||||||
| 07/16/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $3.21 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/12/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Ophthalmology | ||||||
| 06/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $39.07 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $86.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/29/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TTBT01 | TissueTech, Inc. | $1,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 535 | 787 | $283,065 | $64,105 |
| 2022 | 8 | 458 | 625 | $217,371 | $50,579 |
| 2021 | 8 | 482 | 775 | $252,302 | $64,318 |
| 2020 | 7 | 420 | 677 | $212,646 | $45,483 |
Total Patients
1,895
Total Services
2,864
Medicare Billing
$224,485
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 220 | $83,835 | $23,142 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 151 | 266 | $101,365 | $20,278 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 55 | 68 | $36,033 | $7,875 | 21.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 24 | $12,718 | $3,531 | 27.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 23 | 23 | $14,935 | $3,031 | 20.3% |
| 92014 | Established patient complete exam of visual system | Facility | 2023 | 32 | 33 | $12,615 | $2,069 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 21 | $5,655 | $1,119 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $3,770 | $1,109 | 29.4% |
| 92132 | Imaging of front third of eye | Facility | 2023 | 61 | 75 | $7,207 | $968.23 | 13.4% |
| 92025 | Ct scan of cornea | Office | 2023 | 13 | 16 | $2,000 | $419.20 | 21.0% |
| 92132 | Imaging of front third of eye | Office | 2023 | 11 | 11 | $1,144 | $314.16 | 27.5% |
| 92025 | Ct scan of cornea | Facility | 2023 | 13 | 16 | $1,790 | $249.60 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 153 | $57,450 | $16,099 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 126 | 188 | $70,649 | $14,294 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 59 | 70 | $35,995 | $7,726 | 21.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 34 | $17,518 | $5,046 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $9,868 | $1,998 | 20.3% |
| 68761 | Closure of tear duct opening using plug | Facility | 2022 | 13 | 17 | $7,585 | $1,640 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $4,746 | $1,458 | 30.7% |
| 92132 | Imaging of front third of eye | Facility | 2022 | 66 | 81 | $6,715 | $1,060 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 11 | $2,911 | $633.64 | 21.8% |
| 92286 | Imaging of front third of eye using a special microscope | Facility | 2022 | 18 | 19 | $2,078 | $321.31 | 15.5% |
| 92025 | Ct scan of cornea | Facility | 2022 | 14 | 19 | $1,856 | $303.34 | 16.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 213 | $76,254 | $22,501 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 136 | 265 | $94,870 | $21,193 | 22.3% |
About Dr. Pedram Hamrah, M.D
Dr. Pedram Hamrah, M.D is a Ophthalmology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366483778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pedram Hamrah, M.D has received a total of $198,301 in payments from pharmaceutical and medical device companies, with $46,338 received in 2024. These payments were reported across 217 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($176,671).
As a Medicare-enrolled provider, Hamrah has provided services to 1,895 Medicare beneficiaries, totaling 2,864 services with total Medicare billing of $224,485. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Tampa, FL
- Active Since 06/08/2006
- Last Updated 12/07/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1366483778
Products in Payments
- XIIDRA (Drug) $17,562
- Oxervate (Drug) $13,013
- TEPEZZA (Biological) $8,988
- Prokera (Device) $4,511
- TEPEZZA (Drug) $4,242
- Avance Nerve Graft (Device) $2,915
- INVELTYS (Drug) $2,609
- EYSUVIS (Drug) $2,268
- Rocklatan (Drug) $1,600
- Flarex (Drug) $1,365
- TTBT01 (Biological) $1,000
- OXERVATE (Drug) $280.08
- XDEMVY (Drug) $245.25
- VYZULTA (Drug) $174.67
- Rhopressa (Drug) $112.48
- ReSure Sealant (Device) $108.95
- TYRVAYA (Drug) $107.82
- PROKERA (Device) $101.83
- LOTEMAX GEL (Drug) $67.98
- RESTASIS (Drug) $62.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Tampa
Dr. Ivan Suner, M.d, M.D
Ophthalmology — Payments: $493,324
Ophthalmology $493,324
Thomas Newsom, Md, MD
Ophthalmology — Payments: $194,885
Ophthalmology $194,885
Don Perez, Md, MD
Ophthalmology — Payments: $146,801
Ophthalmology $146,801
Marc Peden, Md, MD
Ophthalmology — Payments: $81,565
Ophthalmology $81,565
Steven Maskin, M.d, M.D
Ophthalmology — Payments: $79,491
Ophthalmology $79,491
Dr. Ashley Crane, M.d, M.D
Ophthalmology — Payments: $31,273
Ophthalmology $31,273